STERIS (STE) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$6.0B

Revenue (quarter)

$1.5B

Revenue growth (year over year)

+7.30%

Gross profit (trailing twelve months)

$2.7B

Gross margin

44.43%

Net income (trailing twelve months)

$808.1M

Net income (quarter)

$201.0M

Net income growth (year over year)

+12.92%

Net margin

13.38%

Return on equity

11.37%

EPS (trailing twelve months)

$8.22

Book value per share

$73.95

P/E (trailing twelve months)

26.31

Price to book

2.93

Debt to assets

32.74%

Payout ratio

30.90%

Dividend yield

1.19%

Company profile

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

• Is STERIS (STE) profitable?

  Yes. STERIS earned $808.1M in net income over the trailing twelve months, a net margin of 13.38%.

• How much revenue does STERIS (STE) make?

  STERIS generated $6.0B in revenue over the trailing twelve months, up 7.30% year over year.

• What is STE's P/E ratio?

  STERIS trades at 26.3 times trailing twelve-month earnings, on an EPS of $8.22.

• How do I buy stock in STERIS (STE)?

  STE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.